Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in China

China: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology was 0.1% in 2024. ▼ Falling

Latest (2024)
0.1%
Change on year
unchanged
World rank
135th
of 247 countries
All-time high
0.2%
in 2015
All-time low
0.1%
in 2019
Years of data
10
2015–2024

Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in China, 2015–2024

00.050.10.150.22015201920242015: 0.22016: 0.22017: 0.22018: 0.22019: 0.12020: 0.12021: 0.12022: 0.12023: 0.12024: 0.1

Source: United Nations Statistics Division, SDG Global Database.

Analysis

The most recent figure for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in China is 0.1%, measured in 2024. That is the lowest value across all 10 years on record.

Compared with earlier readings it is down 50.0% over ten years.

Over the whole period, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in China peaked at 0.2% in 2015 and was at its lowest, 0.1%, in 2019.

That places China 135th out of 247 countries with data for 2024, putting it in the middle of the range.

Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in China, year by year

Annual values for Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%) in China, 2015 to 2024.
Year Value Change
2015 0.2% —
2016 0.2% +0.0%
2017 0.2% +0.0%
2018 0.2% +0.0%
2019 0.1% -50.0%
2020 0.1% +0.0%
2021 0.1% +0.0%
2022 0.1% +0.0%
2023 0.1% +0.0%
2024 0.1% +0.0%

China compared with similar countries

  • China's 0.1% is below the median for upper middle income countries, which is 0.2%, 50% of the median. (55 countries reporting)
  • China's 0.1% is below the median for East Asia & Pacific, which is 0.6%, 17% of the median. (33 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2010s 0.2% 0.1% 0.2% 5
2020s 0.1% 0.1% 0.1% 5

Countries ranked near China

  1. 135 Albania 0.1% compare
  2. 135 Algeria 0.1% compare
  3. 135 Armenia 0.1% compare
  4. 135 Australia 0.1% compare
  5. 135 Belize 0.1% compare
  6. 135 Bhutan 0.1% compare
  7. 135 Bolivia (Plurinational State of) 0.1% compare
  8. 135 Denmark 0.1% compare
  9. 135 Dominican Republic 0.1% compare
  10. 135 Gambia 0.1% compare
  11. 135 Guam 0.1% compare
  12. 135 Guyana 0.1% compare
  13. 135 Hungary 0.1% compare
  14. 135 Israel 0.1% compare
  15. 135 Jordan 0.1% compare
  16. 135 Kyrgyzstan 0.1% compare
  17. 135 Lebanon 0.1% compare
  18. 135 Lithuania 0.1% compare
  19. 135 Malaysia 0.1% compare
  20. 135 Oman 0.1% compare
  21. 135 Paraguay 0.1% compare
  22. 135 Peru 0.1% compare
  23. 135 Romania 0.1% compare
  24. 135 Russian Federation 0.1% compare
  25. 135 Serbia 0.1% compare
  26. 135 Singapore 0.1% compare
  27. 135 Thailand 0.1% compare
  28. 135 Trinidad and Tobago 0.1% compare
  29. 135 Tunisia 0.1% compare
  30. 135 Ukraine 0.1% compare
  31. 135 Uzbekistan 0.1% compare
  32. 135 Russia 0.1% compare

See the full ranking of 251 places →

More development goals data for China

All data for China →

Frequently asked questions

What is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in China?
Prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in China was 0.1% in 2024, according to United Nations Statistics Division, SDG Global Database.
What is the highest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in China?
The highest recorded value was 0.2% in 2015.
What is the lowest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in China?
The lowest recorded value was 0.1% in 2019.
How does China rank for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
China ranks 135th out of 247 countries with data for 2024.
Is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology rising or falling in China?
Over the last ten years it is down 50.0%. The long-run trend across the full record is falling.
Where does this China data come from?
The figures come from United Nations Statistics Division, SDG Global Database, published as part of Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 10 observations, free to reuse under UN SDG Global Database (open, attribution requested).

Share, cite or embed this page

Cite this page

Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in China. Statizoid, drawing on United Nations Statistics Division, SDG Global Database. Retrieved 15 October 2026, from https://development-goals.statizoid.com/stat/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/china/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under UN SDG Global Database (open, attribution requested); please keep the attribution.

<a href="https://development-goals.statizoid.com/stat/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/china/">Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in China</a> — Statizoid

About this data

Indicator
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%)
Source
United Nations Statistics Division, SDG Global Database
Licence
UN SDG Global Database (open, attribution requested)
Coverage
251 places, 2,510 data points, 2015–2024
Last refreshed